Molecular pathways: regulation and therapeutic implications of multidrug resistance
Multidrug transporters constitute major mechanisms of MDR in human cancers. The ABCB1
(MDR1) gene encodes a well-characterized transmembrane transporter, termed P …
(MDR1) gene encodes a well-characterized transmembrane transporter, termed P …
[HTML][HTML] Epigenetic basis of lead-induced neurological disorders
T Wang, J Zhang, Y Xu - … journal of environmental research and public …, 2020 - mdpi.com
Environmental lead (Pb) exposure is closely associated with pathogenesis of a range of
neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD) …
neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD) …
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
O Kovalchuk, J Filkowski, J Meservy, Y Ilnytskyy… - Molecular cancer …, 2008 - AACR
Many chemotherapy regiments are successfully used to treat breast cancer; however, often
breast cancer cells develop drug resistance that usually leads to a relapse and worsening of …
breast cancer cells develop drug resistance that usually leads to a relapse and worsening of …
MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties
X Le Guezennec, M Vermeulen… - … and cellular biology, 2006 - Taylor & Francis
The human genome contains a number of methyl CpG binding proteins that translate DNA
methylation into a physiological response. To gain insight into the function of MBD2 and …
methylation into a physiological response. To gain insight into the function of MBD2 and …
ABCG2 expression, function, and promoter methylation in human multiple myeloma
JG Turner, JL Gump, C Zhang, JM Cook, D Marchion… - Blood, 2006 - ashpublications.org
We investigated the role of the breast cancer resistance protein (BCRP/ABCG2) in drug
resistance in multiple myeloma (MM). Human MM cell lines, and MM patient plasma cells …
resistance in multiple myeloma (MM). Human MM cell lines, and MM patient plasma cells …
[HTML][HTML] Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
AA Muggerud, JA Rønneberg, F Wärnberg… - Breast Cancer …, 2010 - Springer
Introduction Ductal carcinoma in situ (DCIS) is a non-invasive lesion of the breast that is
frequently detected by mammography and subsequently removed by surgery. However, it is …
frequently detected by mammography and subsequently removed by surgery. However, it is …
Biology and treatment of rhabdoid tumor
JI Geller, JJ Roth, JA Biegel - Critical Reviews™ in …, 2015 - dl.begellhouse.com
Rhabdoid tumor is a rare, highly aggressive malignancy that primarily affects infants and
young children. These tumors typically arise in the brain and kidney, although extrarenal …
young children. These tumors typically arise in the brain and kidney, although extrarenal …
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer
Purpose: To investigate SGI-110 as a “chemosensitizer” in ovarian cancer and to assess its
effects on tumor suppressor genes (TSG) and chemoresponsiveness-associated genes …
effects on tumor suppressor genes (TSG) and chemoresponsiveness-associated genes …
Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1 …
VP Tryndyak, O Kovalchuk, IP Pogribny - Cancer biology & therapy, 2006 - Taylor & Francis
Cancer cells are characterized by epigenetic dysregulation, including global genome
hypomethylation, regional hypo-and hypermethylation, altered histone modifications, and …
hypomethylation, regional hypo-and hypermethylation, altered histone modifications, and …
[HTML][HTML] DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment …
E Dejeux, JA Rønneberg, H Solvang, I Bukholm… - Molecular cancer, 2010 - Springer
Background Breast cancer is the most frequent cancer in women and consists of a
heterogeneous collection of diseases with distinct histopathological, genetic and epigenetic …
heterogeneous collection of diseases with distinct histopathological, genetic and epigenetic …